BPG is committed to discovery and dissemination of knowledge
Citation
Argyriou K, Kotsakis A. Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”. World J Clin Cases 2022; 10(23): 8425-8427 [PMID: 36159549 DOI: 10.12998/wjcc.v10.i23.8425]
Please LOGIN to submit a new comment.